BGB-45035

DRUG2 trials

Sponsors

BeiGene

Conditions

Atopic DermatitisAutoimmune DiseasesHealthy Adult ParticipantsHealthy ParticipantsHealthy SubjectsHealthy VolunteersPrurigo NodularisRheumatoid Arthritis

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

CompletedNCT06342713

BeiGeneAtopic Dermatitis, Autoimmune Diseases, Healthy Adult Participants +4

Start: 2024-06-20End: 2026-06-02Updated: 2026-06-22

Phase 2

A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

TerminatedNCT07100938

BeiGeneRheumatoid Arthritis

Start: 2025-08-21End: 2026-05-12Updated: 2026-05-28